BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37816330)

  • 1. Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
    Li Z; Lu S
    Cancer Cell; 2023 Oct; 41(10):1699-1701. PubMed ID: 37816330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible.
    Gristina V; La Mantia M; Peri M; Iacono F; Barraco N; Perez A; Viscardi G; Cutaia S; Russo TDB; Anwar Z; Incorvaia L; Fulfaro F; Vieni S; Pantuso G; Graceffa G; Russo A; Galvano A; Bazan V
    Crit Rev Oncol Hematol; 2023 Feb; 182():103899. PubMed ID: 36596401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
    Romero A; Serna-Blasco R; Calvo V; Provencio M
    Curr Treat Options Oncol; 2021 Aug; 22(10):86. PubMed ID: 34424428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients.
    Santarpia M; Funel N; Ali A; Giovannetti E
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706
    [No Abstract]   [Full Text] [Related]  

  • 5. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC).
    Sardarabadi P; Kojabad AA; Jafari D; Liu CH
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsy - Possibilities for Monitoring the Therapeutic Response in Non-Small Cell Lung Cancer.
    Raycheva GA; Ivanov HY; Grudeva-Popova ZG
    Folia Med (Plovdiv); 2021 Dec; 63(6):839-846. PubMed ID: 35851241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer.
    Al-Obeidi E; Riess JW; Malapelle U; Rolfo C; Gandara DR
    Hematol Oncol Clin North Am; 2023 Jun; 37(3):475-487. PubMed ID: 37024388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer.
    Li FQ; Cui JW
    Crit Rev Oncol Hematol; 2022 Nov; 179():103800. PubMed ID: 36031171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.
    Bertoli E; De Carlo E; Basile D; Zara D; Stanzione B; Schiappacassi M; Del Conte A; Spina M; Bearz A
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer.
    Malapelle U; Pisapia P; Addeo A; Arrieta O; Bellosillo B; Cardona AF; Cristofanilli M; De Miguel-Perez D; Denninghoff V; Durán I; Jantus-Lewintre E; Nuzzo PV; O'Byrne K; Pauwels P; Pickering EM; Raez LE; Russo A; Serrano MJ; Gandara DR; Troncone G; Rolfo C
    Expert Rev Mol Diagn; 2021 Nov; 21(11):1165-1178. PubMed ID: 34570988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.
    Bouhlel L; Hofman V; Maschi C; Ilié M; Allégra M; Marquette CH; Audigier-Valette C; Thariat J; Hofman P
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1087-1092. PubMed ID: 29069959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
    Zheng MM; Li YS; Jiang BY; Tu HY; Tang WF; Yang JJ; Zhang XC; Ye JY; Yan HH; Su J; Zhou Q; Zhong WZ; Yang XN; Guo WB; Chuai S; Zhang Z; Chen HJ; Wang Z; Liu C; Wu YL
    J Thorac Oncol; 2019 May; 14(5):924-932. PubMed ID: 30659989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-educated platelet as liquid biopsy in lung cancer patients.
    Liu L; Lin F; Ma X; Chen Z; Yu J
    Crit Rev Oncol Hematol; 2020 Feb; 146():102863. PubMed ID: 31935617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era.
    Palmieri M; Frullanti E
    Med Sci (Basel); 2023 Jan; 11(1):. PubMed ID: 36649045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of circulating free DNA in the management of NSCLC.
    Esposito Abate R; Pasquale R; Fenizia F; Rachiglio AM; Roma C; Bergantino F; Forgione L; Lambiase M; Sacco A; Piccirillo MC; Morabito A; Normanno N
    Expert Rev Anticancer Ther; 2019 Jan; 19(1):19-28. PubMed ID: 30462523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.